PO² is a pharmacy in Paliseul. Private Limited, started on 24 February 2015, 1 establishment.

What is the address of PO²?

The registered office of PO² is located at Rue Paul-Verlaine 1, 6850 Paliseul.

Is PO² still active?

Yes. According to the CBE (30 October 2026) PO² is active, legal situation “Normale toestand”, started on 24 February 2015.

Is PO² registered on Peppol?

Yes, PO² is registered on the Peppol network with ID 0208:0598929369.

What is the enterprise number of PO²?

The enterprise number of PO² is BE0598929369.

When was PO² founded?

PO² was founded on 24 February 2015.

Who are the directors of PO²?

According to the 2025 annual accounts, the directors of PO² are: Perrinne DELMOITIE, Philippe ROBYN.

Is PO² a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 February 2015; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PO² make in 2025?

PO² recorded a loss after taxes of € 48,617 in financial year 2025.

What is the revenue of PO²?

As a small company, PO² is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 96,054.

PO² (Private Limited) - Paliseul - BE0598929369

Dossier PO², printed on 30 October 2026 from databakkes.be/en/0598929369/po. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PO² from Paliseul, company number BE0598929369, closed financial year 2025 with a result of € -48,617 after tax. For that financial year PO² recorded a gross margin of € 96,054 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 97,548 to € -48,617. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Healthy

€ 1.1 million

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -48,617

▼ still € 97,548 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 359,699

▲ € 286,218 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 1 million.

People and assets in 2025

Vehicles and equipment

€ 3,479

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 961,249

▲ 41% vs 2024

€ 136,971 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 41,765

▲ € 36,201 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,121

▲ 147% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 145,352 Gross margin 2022: € 145,352 First fiscal year in the series	€ 128,378 Gross margin 2023: € 128,378 ▼ 12% vs 2022 (€ 145,352) Unfavourable step	€ 133,799 Gross margin 2024: € 133,799 ▲ 4% vs 2023 (€ 128,378) Favourable step	€ 96,054 Gross margin 2025: € 96,054 ▼ 28% vs 2024 (€ 133,799) Unfavourable step	▼ 28%
Profit after taxes	€ 176,725 Profit after taxes 2022: € 176,725 First fiscal year in the series	€ 109,540 Profit after taxes 2023: € 109,540 ▼ 38% vs 2022 (€ 176,725) Unfavourable step	€ 97,548 Profit after taxes 2024: € 97,548 ▼ 11% vs 2023 (€ 109,540) Unfavourable step	€ -48,617 Profit after taxes 2025: € -48,617 ▼ € 146,165 vs 2024 (€ 97,548) Unfavourable step	▼ € 146,165
Equity	€ 898,181 Equity 2022: € 898,181 First fiscal year in the series	€ 1,006,889 Equity 2023: € 1,006,889 ▲ 12% vs 2022 (€ 898,181) Favourable step	€ 1,104,437 Equity 2024: € 1,104,437 ▲ 10% vs 2023 (€ 1,006,889) Favourable step	€ 1,055,820 Equity 2025: € 1,055,820 ▼ 4% vs 2024 (€ 1,104,437) Unfavourable step	▼ 4%
Total debts	€ 1,435,305 Total debts 2022: € 1,435,305 First fiscal year in the series	€ 1,323,689 Total debts 2023: € 1,323,689 ▼ 8% vs 2022 (€ 1,435,305) Favourable step	€ 1,136,103 Total debts 2024: € 1,136,103 ▼ 14% vs 2023 (€ 1,323,689) Favourable step	€ 1,180,322 Total debts 2025: € 1,180,322 ▲ 4% vs 2024 (€ 1,136,103) Unfavourable step	▲ 4%
Cash	€ 171,918 Cash 2022: € 171,918 First fiscal year in the series	€ 177,320 Cash 2023: € 177,320 ▲ 3% vs 2022 (€ 171,918) Favourable step	€ 73,481 Cash 2024: € 73,481 ▼ 59% vs 2023 (€ 177,320) Unfavourable step	€ 359,699 Cash 2025: € 359,699 ▲ € 286,218 vs 2024 (€ 73,481) Favourable step	▲ € 286,218
Land & buildings	-	-	-	€ 265,582 Land & buildings 2025: € 265,582 First fiscal year in the series
Retained profit	€ 849,581 Retained profit 2022: € 849,581 First fiscal year in the series	€ 958,289 Retained profit 2023: € 958,289 ▲ 13% vs 2022 (€ 849,581) Favourable step	€ 1,055,837 Retained profit 2024: € 1,055,837 ▲ 10% vs 2023 (€ 958,289) Favourable step	€ 1,007,220 Retained profit 2025: € 1,007,220 ▼ 5% vs 2024 (€ 1,055,837) Unfavourable step	▼ 5%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 833) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 905,639 Bank debt 2022: € 905,639 First fiscal year in the series	€ 792,328 Bank debt 2023: € 792,328 ▼ 13% vs 2022 (€ 905,639) Favourable step	€ 681,849 Bank debt 2024: € 681,849 ▼ 14% vs 2023 (€ 792,328) Favourable step	€ 961,249 Bank debt 2025: € 961,249 ▲ 41% vs 2024 (€ 681,849) Unfavourable step	▲ 41%
Balance sheet total	€ 2,333,487 Balance sheet total 2022: € 2,333,487 First fiscal year in the series	€ 2,330,578 Balance sheet total 2023: € 2,330,578 Unchanged (€ 2,333,487) Unchanged	€ 2,240,540 Balance sheet total 2024: € 2,240,540 ▼ 4% vs 2023 (€ 2,330,578) Unchanged	€ 2,328,641 Balance sheet total 2025: € 2,328,641 ▲ 4% vs 2024 (€ 2,240,540) Unchanged	▲ 4%

Key figures of PO², fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PO²?

What happened at PO² in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: loss of € 48,617 (▼ € 146,165 vs 2024). Source: NBB ↗
Feb 24, 2015 New establishment in Paliseul. KBO
Feb 24, 2015 Start of the company according to the CBE. KBO

In short

From € 176,725 profit in 2022 to € 48,617 loss in 2025.

Paid € 113,825 in corporate taxes since 2022.

Best year ever: 2022, with € 176,725 profit.

Paid out € 1,633 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Perrinne DELMOITIE

Philippe ROBYN

PO²

PALISEUL PHARMA 99%

Behind PO² are Perrinne DELMOITIE and Philippe ROBYN. It owns 99% of PALISEUL PHARMA itself.

Directors

According to the 2025 annual accounts

Perrinne DELMOITIE

Director

Philippe ROBYN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Paul-Verlaine 1

6850 Paliseul

2.240.292.796

Grand-Place 16

6850 Paliseul

Active since 24 February 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0598.929.369
VAT number: BE 0598.929.369
Registered office: Rue Paul-Verlaine 1, 6850 Paliseul
Names & denominations: PO²
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 February 2015
Peppol: Active · Active since 24 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PO²